Value of SRS Over Conventional Fractionation for Bone Metastases
Yoshiya Yamada, MD, Radiation Oncologist at Memorial Sloan Kettering Cancer Center in New York City discusses radiosurgery (SRS) versus conventional fractionated radiotherapy for spinal and bone metastases. He begins by discussing histologic classification in terms of radiosensitivity and radioresistance and how that applies to spinal metastases before giving an overview of the results of several related studies.
Spine Setup and Monitoring ETD 1.0
Clinical Outcome and Side Effects After Spine Radiosurgery
Local Disease Control for Spinal Metastases Following “Separation Surgery”...
Early Experience with Elements Spine SRS
Spinal Cord and Peripheral Nerve Tolerance to SRS
International Spine Radiosurgery Consortium Consensus Guidelines...
Spine Metastasis Multi-Modality Decision Framework
Radiosurgery from Brain to Spine: 20 Years Experience
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login